A Phase 1/2 Study to Investigate CRB-701 in Solid Tumors
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Ari Rosenberg, MD
University of Chicago
Principal Investigator - David Pinato, MD
Imperial College London
Principal Investigator - Ian Hodgson, PhD
Corbus International Ltd
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
41 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Icm-Val D'Aurelle
Montpellier, France
Recruiting - Chu de Poitiers
Poitiers, France
Recruiting - Institut de Cancerologie de L'Ouest
Saint-Herblain, France
Recruiting - Gustave Roussy
Villejuif, France
Recruiting
- Careggi University Hospital
Florence, Italy
Recruiting - European Institute of Oncology Irccs
Milan, Italy
Recruiting - Fondazione Policlinico Gemelli, Irccs
Rome, Italy
Recruiting - Centro Richerche Cliniche Di Verona
Verona, Italy
Recruiting
- Institute of Oncology/arensia Exploratory Medicine
Chisinau, Moldova
Withdrawn
- Aresnsia Research Clinic Bucharest
Bucharest, Romania
Recruiting - Aresnsia Research Clinic Cluj-Napoca
Cluj-Napoca, Romania
Recruiting - Centrul de Oncologie Euroclinic
Iași, Romania
Recruiting - Centrul de Oncologie Sf. Nectarie
Iași, Romania
Recruiting
- Barcelona Iob Hospital Quironsalud (next)
Barcelona, Spain
Recruiting - Vall D-Hebron Institut D'Oncologia
Barcelona, Spain
Recruiting - Fundacion Jimenez Diaz (start)
Madrid, Spain
Recruiting - Hospital Clinico Universitario de Valencia
Valencia, Spain
Recruiting
- University of Birmingham Nhs Foundation Trust
Birmingham, United Kingdom
Recruiting - University of Cambridge Nhs Foundation Trust
Cambridge, United Kingdom
Recruiting - Velindre Cancer Centre
Cardiff, United Kingdom
Recruiting - Leeds University Hospitals Nhs Trust
Leeds, United Kingdom
Recruiting - Guy'S and St Thomas' Clinical Research Facility
London, United Kingdom
Recruiting - Imperial Experimental Cancer Medicine Centre
London, United Kingdom
Recruiting - the Christie Hospital
Manchester, United Kingdom
Recruiting - University of Liverpool - Clatterbridge Medical Centre
Metropolitan Borough of Wirral, United Kingdom
Recruiting - University of Southampton
Southampton, United Kingdom
Recruiting
- O'Neal Comprehensive Cancer Center at University of Alabama-Birmingham
Birmingham, Alabama, United States
Recruiting - City of Hope Cancer Center
Duarte, California, United States
Recruiting - Moores Cancer Centre at Uc San Diego Health
San Diego, California, United States
Recruiting - Helen Diller Family Comprehensive Cancer Center - Ucsf
San Francisco, California, United States
Recruiting - Rocky Mountain Cancer Centres
Denver, Colorado, United States
Active, not recruiting - Yale Cancer Center
New Haven, Connecticut, United States
Recruiting - Florida Cancer Specialists
Orlando, Florida, United States
Recruiting - University of Chicago
Chicago, Illinois, United States
Recruiting - Hope and Healing Cancer Center
Hinsdale, Illinois, United States
Active, not recruiting - Dana-Faber Cancer Institute
Boston, Massachusetts, United States
Recruiting - Nebraska Hematology Oncology
Lincoln, Nebraska, United States
Active, not recruiting - Carolina Biooncology Institute
Huntersville, North Carolina, United States
Active, not recruiting - Texas Oncology
Tyler, Texas, United States
Recruiting - Virginia Cancer Specialists
Fairfax, Virginia, United States
Active, not recruiting
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 1 Apr 2024
- Primary completion
- 16 Jan 2027
- Completion
- 27 Jan 2027
- Last update posted
- 8 Jan 2026
- Registered enrollment
- 348
- Registry id
- NCT06265727
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.